Market Tracker

10/24 2:50pm ET
5.81
Real-Time Quote
 +0.20 / +3.57%
Today’s Change
5.31
Today|||52-Week Range
33.70
-45.60%
Year-to-Date
No recent news for Endocyte Inc.

Today’s Trading

Previous close5.61
Today’s open5.61
Day’s range5.57 - 5.87
Volume710,851
Average volume (3 months)1,447,495
Market cap$233.1M
Dividend yield--
Data as of 2:34pm ET, 10/24/2014

Growth & Valuation

Earnings growth (last year)-4.17%
Earnings growth (this year)+93.62%
Earnings growth (next 5 years)--
Revenue growth (last year)+87.04%
P/E ratio21.6
Price/Sales5.93
Price/Book2.30

Competitors

 Today’s
change
Today’s
% change
ALIMAlimera Sciences Inc+0.56+10.18%
MRTXMirati Therapeutics ...-0.91-5.10%
GALEGalena Biopharma Inc-0.04-2.12%
ADMSAdamas Pharmaceutica...+0.04+0.27%
Data as of 2:49pm ET, 10/24/2014

Financials

Next reporting dateOctober 30, 2014
EPS forecast (this quarter)-$0.20
Annual revenue (last year)$64.9M
Annual profit (last year)-$18.0M
Net profit margin-27.80%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
P. Ron Ellis
Chief Operating &
Financial Officer
Michael A. Sherman
Corporate headquarters
West Lafayette, Indiana

Forecasts